Literature DB >> 17971744

An efficient synthesis of a spirocyclic oxindole analogue.

Dawei Teng1, Hongxing Zhang, A Mendonca.   

Abstract

An efficient, scaleable synthesis approach towards the spirocyclic oxindole analogue 1'-(tert-butoxycarbonyl)-2-oxospiro[indoline-3,4'-piperidine]-5-carboxylic acid (1) is described. The key steps are dianion alkylation and cyclization of ethyl 2- oxindoline-5-carboxylate (4) and demethylation of the resulting spirocyclic oxindole ethyl 1'-methyl-2-oxospiro[indoline-3,4'-piperidine]-5-carboxylate (5). The target compound was obtained in an overall yield of 35 % over eight steps without resorting to chromatographic purification.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17971744      PMCID: PMC6148541          DOI: 10.3390/11090700

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  8 in total

1.  The chemistry of oxindole.

Authors:  W C SUMPTER
Journal:  Chem Rev       Date:  1945-12       Impact factor: 60.622

2.  Substituted oxindoles. 3. Synthesis and pharmacology of some substituted oxindoles.

Authors:  J Walker; R W Daisley; A H Beckett
Journal:  J Med Chem       Date:  1970-09       Impact factor: 7.446

3.  N-hydroxyalkyl derivatives of 3 beta-phenyltropane and 1-methylspiro[1H-indoline-3,4'-piperidine]: vesamicol analogues with affinity for monoamine transporters.

Authors:  S M Efange; A P Kamath; A B Khare; M P Kung; R H Mach; S M Parsons
Journal:  J Med Chem       Date:  1997-11-21       Impact factor: 7.446

4.  Orally active, nonpeptide oxytocin antagonists.

Authors:  B E Evans; J L Leighton; K E Rittle; K F Gilbert; G F Lundell; N P Gould; D W Hobbs; R M DiPardo; D F Veber; D J Pettibone
Journal:  J Med Chem       Date:  1992-10-16       Impact factor: 7.446

5.  Synthesis and biological activities of phenyl piperazine-based peptidomimetic growth hormone secretagogues.

Authors:  K J Barakat; K Cheng; W W Chan; B S Butler; T M Jacks; K D Schleim; D F Hora; G J Hickey; R G Smith; A A Patchett; R P Nargund
Journal:  Bioorg Med Chem Lett       Date:  1998-06-02       Impact factor: 2.823

6.  Serine derived NK1 antagonists. 1: The effect of modifications to the serine substituents.

Authors:  J M Elliott; M A Cascieri; G Chicchi; S Davies; F J Kelleher; M Kurtz; T Ladduwahetty; R T Lewis; A M MacLeod; K J Merchant; S Sadowski; G I Stevenson
Journal:  Bioorg Med Chem Lett       Date:  1998-07-21       Impact factor: 2.823

7.  Syntheses and in vitro evaluation of 4-(2-aminoethyl)-2(3H)-indolones and related compounds as peripheral prejunctional dopamine receptor agonists.

Authors:  R M DeMarinis; G Gallagher; R F Hall; R G Franz; C Webster; W F Huffman; M S Schwartz; C Kaiser; S T Ross; J W Wilson
Journal:  J Med Chem       Date:  1986-06       Impact factor: 7.446

8.  Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.

Authors:  A A Patchett; R P Nargund; J R Tata; M H Chen; K J Barakat; D B Johnston; K Cheng; W W Chan; B Butler; G Hickey
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

  8 in total
  1 in total

1.  Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists.

Authors:  Stephen Hanessian; Thomas Jennequin; Nicolas Boyer; Vincent Babonneau; Udaykumar Soma; Clotilde Mannoury la Cour; Mark J Millan; Guillaume De Nanteuil
Journal:  ACS Med Chem Lett       Date:  2014-02-13       Impact factor: 4.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.